Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,077 public trials 1,842 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Recruiting

Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer

NCT05401110

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Cedars-Sinai Cancer at Beverly Hills (THO) Beverly Hills, California, United States
  • Cedars-Sinai Cancer at The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Cedars-Sinai Cancer at SOCC Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View Trial Details
Recruiting

A Study of ZW251 in Participants With Advanced Solid Tumors

NCT07164313

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +21 more
Locations
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles - Cancer Care - Santa Monica (UCLA) Santa Monica, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • START Midwest Grand Rapids, Michigan, United States
View all 25 locations
View Trial Details
Recruiting

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

NCT05657873

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • BAPTIST ALLIANCE - MCI (Data Collection Only) Miami, Florida, United States
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
View Trial Details
Recruiting

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

NCT06239194

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +74 more
Locations
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Sylvester Comprehensive Cancer Center - University of Miami Health System Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

NCT06116682

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 248 locations
View Trial Details
Recruiting

Environment and Lung Cancer

NCT05119244

Conditions
Cannabis Use, Chemically-Induced Disorders, Lung Diseases, +9 more
Locations
  • Centre Chirurgical Marie Lannelongue Le Plessis-Robinson, France
  • Hopital Paris Saint Joseph Paris, France
  • Institut Gustave Roussy Villejuif, France
View Trial Details
Recruiting

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

NCT06800339

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Maryland Proton Treatment Center Baltimore, Maryland, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • Upper Chesapeake- Kaufman Cancer Center Bel Air, Maryland, United States
  • Baltimore Washington Medical Center- Tate Cancer Center Glen Burnie, Maryland, United States
View Trial Details
Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT06350097

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Fountain Valley, California, United States
  • Research Site Los Alamitos, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 166 locations
View Trial Details

Related conditions